Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: SPYRE THERAPEUTICS, INC., SPYRE THERAPEUTICS, INC.
Firm Income Reported for This Client
$70K
Not substituted for client expenses
SEC Insider
$452.8M
346 transactions
Summary
Spyre Therapeutics, Inc. (SYRE) is an organization. Its political footprint includes $70K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs. Political activity spans from 2025 to 2026.